Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $35.6 Million - $45.4 Million
-300,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $34.4 Million - $41 Million
300,000
300,000 $35.2 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.